July 1, 2026 · Form 4 insider transaction
Sandler Laura Lee sold 2,263 shares of Oruka Therapeutics, Inc. at $94.75 per share, a transaction worth $214.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.38 to $95.19, inclusive.